CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in SNDX — Syndax Pharmaceuticals Inc
CIK 884546
SAN FRANCISCO, CA
Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,800,663
+$1,094,689 QoQ
Shares Held
814,303
+13.9% QoQ
Ownership
0.912%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 242 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. SNDX ranks #77 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in SNDX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,800,663 | 814,303 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,705,974 | 715,153 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,283,178 | 727,424 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,062,338 | 719,034 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,670,783 | 712,310 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,472,878 | 689,693 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $9,317,760 | 704,823 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $13,396,979 | 695,947 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,436,659 | 654,489 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $15,117,926 | 635,207 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $12,469,445 | 577,022 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $7,353,900 | 506,467 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $10,283,139 | 491,311 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $9,929,905 | 470,166 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,420,458 | 448,741 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $9,254,457 | 385,121 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,866,852 | 356,905 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,931,863 | 341,304 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,698,252 | 305,996 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,781,290 | 302,527 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $4,629,564 | 269,631 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,163,661 | 230,933 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,324,968 | 194,468 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,709,463 | 183,568 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $984,329 | 66,419 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $611,665 | 55,758 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||